Timothy Larsen
Overview
Explore the profile of Timothy Larsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park S, Lichtensztajn D, Yang J, Wu J, Shariff-Marco S, Stram D, et al.
Ann Am Thorac Soc
. 2025 Jan;
PMID: 39847697
Rationale: Globally, in 2019, chronic obstructive pulmonary disease (COPD) was the third leading cause of death. While tobacco smoking is the predominant risk factor, the role of long-term air pollution...
2.
Dye C, Dela Cruz M, Larsen T, Nair G, Marinescu K, Suboc T, et al.
Am Heart J Plus
. 2024 Mar;
33:100309.
PMID: 38510554
Patients with heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have increased mortality and increased risk of stroke. Due to the heterogeneous nature of both disease processes,...
3.
Sanders D, Du-Fay-de-Lavallaz J, Winterfield J, Santangeli P, Liang J, Rhodes P, et al.
J Cardiovasc Electrophysiol
. 2024 Jan;
35(4):625-638.
PMID: 38174841
Introduction: The utility of ablation index (AI) to guide ventricular tachycardia (VT) ablation in patients with structural heart disease is unknown. The aim of this study was to assess procedural...
4.
Ravi V, Vipparthy S, Sanders D, Huang H, Larsen T, Trohman R, et al.
JACC Clin Electrophysiol
. 2023 Oct;
9(12):2652-2654.
PMID: 37855767
No abstract available.
5.
Ravi V, Winterfield J, Liang J, Larsen T, Dye C, Sanders D, et al.
Arrhythm Electrophysiol Rev
. 2023 Aug;
12:e04.
PMID: 37600155
Ventricular tachycardia (VT) is a significant cause of morbidity and mortality in patients with ischaemic and non-ischaemic cardiomyopathies. In most patients, the primary strategy of VT catheter ablation is based...
6.
Hoster C, Rahman A, Goyal A, Peigh G, Trohman R, Knight B, et al.
J Interv Card Electrophysiol
. 2023 Jan;
PMID: 36596954
Background: Subcutaneous implantable cardioverter-defibrillators (S-ICD) are an alternative to transvenous ICDs for patients without a need for cardiac pacing. Obese patients have been proposed to be at higher risk for...
7.
Dye C, Engelstein E, Swearingen S, Murphy J, Larsen T, Volgman A
Front Cardiovasc Med
. 2022 Oct;
9:987247.
PMID: 36225957
Arrhythmias and sudden cardiac death with sexual activity are rare. However, the demographics are changing regarding the cardiovascular patients at risk for these events. Recent studies have highlighted that the...
8.
Khalil C, Vipparthy S, Kenigsberg D, Ravi V, Lazar S, Doukky R, et al.
J Cardiovasc Electrophysiol
. 2022 Aug;
33(11):2389-2393.
PMID: 36041214
Introduction: With the increasing adoption of left atrial appendage occlusion (LAAO) procedures and the eligibility of patients for pulmonary vein isolation (PVI) post device placement, we examined the feasibility and...
9.
Ravi V, Poudyal A, Khanal S, Khalil C, Vij A, Sanders D, et al.
J Interv Card Electrophysiol
. 2022 Jun;
66(1):161-175.
PMID: 35759160
Background: In patients with cardiomyopathy, radiofrequency catheter ablation (CA) for ventricular tachycardia (VT) is an adjunctive and alternative treatment option to long-term anti-arrhythmic drug therapy. We sought to compare CA...
10.
Vijayaraman P, Zalavadia D, Haseeb A, Dye C, Madan N, Skeete J, et al.
Heart Rhythm
. 2022 May;
19(8):1263-1271.
PMID: 35500791
Background: Cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) is well-established therapy in patients with reduced left ventricular ejection fraction (LVEF) and bundle branch block or indication for pacing. Conduction...